Baylor College of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Baylor College of Medicine sits in the top decile of US sponsors by registered trial count (#56 of 15,742 sponsors by registered trial count).

616 total trials 93 currently recruiting 376 completed early-phase tilt top decile by trial count

Baylor College of Medicine: 616 sponsored US clinical trials, 93 recruiting.

Baylor College of Medicine sponsors 616 registered US clinical trials on ClinicalTrials.gov, 93 of them currently recruiting, and 376 completed. 59 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Non-Hodgkin Lymphoma, with 7 trials.

Top-decile sponsor footprint

Baylor College of Medicine ranks in the top decile of sponsors by registered trial count (#56 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 47/100

376 of 452 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

616 total, page 8 of 13

COMPLETED NA

Development & Testing of a Decision Aid for LVAD Placement

NCT02248974

TERMINATED Phase 4

Use Of Oral Fidaxomicin Vs. Oral Vancomycin For Clostridium Difficile Infection In Patients With Spinal Cord Injury

NCT02355938

COMPLETED NA

Individualized High Dose Methotrexate to Treat Cancer in Children Who Have a Significant Risk for Side Effects to Methotrexate

NCT02076997

COMPLETED

Use of Baxter Animated Retching Faces (BARF) Scale to Measure Nausea in Children Who Speak Spanish

NCT02007109

COMPLETED

Catheter Biofilm Microbiome in Infected Neonatal Catheters.

NCT01985737

COMPLETED

Fetal Cardiac Strain Imaging Research

NCT01993264

COMPLETED

Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases

NCT01988753

COMPLETED Early Phase 1

Novel Dose Escalation to Predict Treatment With Hydroxyurea

NCT02042222

COMPLETED Phase 3

Multicenter Evaluation of Memory Remediation After TBI With Donepezil

NCT02255799

COMPLETED NA

One-Day Intervention for Depression and Impairment in Migraine Patients

NCT02108678

COMPLETED Phase 1

Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults

NCT01717950

TERMINATED Phase 2

Eosinophilic Esophagitis Clinical Therapy Comparison Trial

NCT01821898

COMPLETED NA

Study Examining Parker-Flex Endotracheal Tube for Obese Patients

NCT01894178

COMPLETED Phase 1

A Comparison Between Two Video Laryngoscopes,in Successfully Intubating Pediatric Mannequins w/wo Difficult Airways

NCT02198742

TERMINATED NA

Randomized Clinical Trial of Early Delivery in Fetal Gastroschisis vs. Routine Care

NCT01884324

COMPLETED

Clinical Use of Baxter Animated Retching Faces (BARF) Scale in Children

NCT02421952

TERMINATED Phase 2

Pentoxifylline Therapy in Biliary Atresia

NCT01774487

COMPLETED Phase 4

Effects of Dry Eye Treatments on the Ocular Surface

NCT01797822

COMPLETED Phase 1

Carisbamate as a Potential Treatment for Alcohol Dependence

NCT02435381

TERMINATED Phase 1

Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide

NCT01604031

COMPLETED NA

Effect of Vitamin D in Diets of Preterm Infants

NCT01698840

COMPLETED Early Phase 1

Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies

NCT01760226

TERMINATED Phase 2

A Pilot Study of Candesartan as a Treatment for Cocaine Dependence

NCT01938664

COMPLETED Phase 2

Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A

NCT01858922

COMPLETED NA

VA Home-Based Emotional Learning With Practical Skills

NCT01685528

COMPLETED NA

Efficacy of a Brief Behavioral Intervention to Treat ADHD and Disruptive Behaviors In Preschoolers

NCT01919073

COMPLETED NA

Nitric Oxide Flux and Ureagenesis in Argininosuccinate Synthetase Deficiency (ASSD)(Citrullinemia I)

NCT01610089

COMPLETED Phase 4

A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes

NCT01718093

COMPLETED

The Effects of Puberty and Weight on Sugar Metabolism in Children

NCT01718080

COMPLETED NA

Calmer Life: Testing the Effectiveness of a Treatment for Anxiety

NCT01702220

TERMINATED Phase 4

A Comparison Trial Between PCA and Epidural Analgesia for Pectus Excavatum Repair

NCT02056301

COMPLETED NA

Increasing Vegetable Intake in Children

NCT02216968

COMPLETED Phase 1

Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel Adjuvant

NCT01385189

COMPLETED NA

Cognition in Motion

NCT02927275

COMPLETED

Validation of a Digital Diet Method for Use With Preschoolers

NCT01725347

COMPLETED NA

Text Messages and Physical Activity Among Teens

NCT01482234

COMPLETED Phase 1

Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases

NCT01447056

TERMINATED Phase 4

Effect of Saxagliptin Treatment on Myocardial Fat Content, and Monocyte Inflammation

NCT01548651

COMPLETED Phase 1

Doxazosin FOR Ptsd

NCT02308202

COMPLETED NA

The Effects of Breakfast on Neuropsychological Functioning

NCT01943604

COMPLETED NA

Food, Fun, & Fitness Internet Program for Girls: Outcome Evaluation

NCT01481948

COMPLETED

Iron Absorption in Vegetarian Children

NCT01489007

COMPLETED NA

Human Milk Cream as a Caloric Supplement in Pre-Term Infants

NCT01487928

COMPLETED

Endobronchial Ultrasound Guided Transbronchial Needle Aspiration Performed Under General Anesthesia Versus Moderate Sedation

NCT01430962

COMPLETED Phase 1

Pramipexole as a Treatment for Cocaine Dependence

NCT01651377

COMPLETED NA

Exercise as a Behavioral Treatment for Cocaine Dependence

NCT01601743

COMPLETED NA

Pancreas Resection With and Without Drains

NCT01441492

TERMINATED NA

Intraoperative Methadone vs Morphine for Postoperative Pain Control in Patients Undergoing Surgery of the Tibia

NCT01430182

COMPLETED NA

Tranexamic Acid (TA) vs Combined Oral Contraceptive (COCP) Pilot Study

NCT01428713

COMPLETED Phase 4

A Trial Of Oral Chloral Hydrate Versus Intranasal Dexmedetomidine For Sedated Abr Exams

NCT01255904

← Previous Page 8 of 13 Next →

Phase Distribution

PhaseTrial count
Phase 1 173
Phase 2 59
Phase 3 13
Phase 4 46

What is open in the Baylor College of Medicine pipeline

93 recruiting of 616 indexed (15% open); 376 completed (61%).

Phase mix: 59 late (III/IV) vs 232 early (I/II) (early-phase heavy).

Top condition: Non-Hodgkin Lymphoma (7 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Baylor College of Medicine: open-pipeline peers nationwide

Peers matched on 616 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Baylor College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 0%5%10%15%20% Total trials Recruiting share Baylor College of MedicineUniversity of Southern CaliforniaUS Department of Veterans AffairsUniversity of RochesterJanssen Research & DevelopmentStanford UniversityBaylor UniversityCornell University59th Medical Wing
Baylor College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Baylor College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 616 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Baylor College of Medicine page

616 registered trials is a research-attention snapshot, not an endorsement of Baylor College of Medicine or any single study.

  • 93 of Baylor College of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Non-Hodgkin Lymphoma is the condition Baylor College of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Non-Hodgkin Lymphoma trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Baylor College of Medicine pipeline card: 616 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.